| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $36.6M | +38.2% |
| SG&A Expense | $26.8M | -3.6% |
| Operating Income | -$63.5M | -23.0% |
| Interest Expense | $1.1M | +129.8% |
| Pre-tax Income | -$63.3M | -19.3% |
| Income Tax | $70K | +70.7% |
| Net Income | -$30.6M | -267.2% |
| EPS (Basic) | -$1.28 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.0M | -77.0% |
| Short-term Investments | $98.5M | — |
| Current Assets | $100.9M | -15.6% |
| Total Assets | $108.0M | -13.0% |
| Current Liabilities | $4.8M | +82.4% |
| Long-term Debt | $30.0M | — |
| Total Liabilities | $34.0M | +1188.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.5M | -44.3% |
| Capital Expenditures | $1.6M | +220.0% |
| Investing Cash Flow | -$72.4M | — |
| Financing Cash Flow | $29.0M | -62.4% |
| Free Cash Flow | -$48.1M | -47.0% |
| -197.7% |
| EPS (Diluted) | -$1.28 | -197.7% |
| Stockholders' Equity |
| $36.9M |
| -22.3% |